Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis
- PMID: 23162615
- PMCID: PMC3499607
- DOI: 10.3892/ol.2012.862
Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis
Abstract
Previous experimental evidence has suggested that fatty acid synthase (FASN) may be involved in cancer metastasis. However, its role has been poorly evaluated in osteosarcoma. The aim of this study was to investigate the correlation of FASN expression with pulmonary metastasis and the correlation of FASN expression with the Ki-67 antigen, a proliferation marker, in patients with osteosarcoma of the extremities. The expression of FASN protein and Ki-67 was detected by immunohistochemistry of biopsy tissues from 136 patients with osteosarcoma of the extremities and 21 cases of osteoenchondroma. Positive expression of the FASN protein was observed and located in the cytoplasm. The positive expression rate of FASN was 63.2% in osteosarcoma and 28.6% in osteoenchondroma (p<0.05). The expression levels of the FASN protein were higher in the cases with lung metastasis compared to those without metastasis (p<0.01). The percentage of Ki-67 stained nuclei in osteosarcoma with pulmonary metastasis and in those without was 43.43±10.05 and 25.41±6.68%, respectively (p<0.01). There was a positive correlation between FASN and Ki-67 protein expression in osteosarcoma (Spearman's rho, F=43.05, R=0.734). Therefore, FASN may be a promising target in the treatment of osteosarcoma metastasis.
Figures



Similar articles
-
Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration.Indian J Pathol Microbiol. 2012 Apr-Jun;55(2):163-9. doi: 10.4103/0377-4929.97849. Indian J Pathol Microbiol. 2012. PMID: 22771636
-
Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8777-83. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674245 Free PMC article.
-
Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.Int J Mol Med. 2014 Mar;33(3):633-9. doi: 10.3892/ijmm.2013.1602. Epub 2013 Dec 23. Int J Mol Med. 2014. PMID: 24366211
-
[Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Mar;46(2):228-33. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 25924435 Chinese.
-
Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.Cell Death Dis. 2019 Apr 1;10(4):298. doi: 10.1038/s41419-019-1532-2. Cell Death Dis. 2019. PMID: 30931932 Free PMC article.
Cited by
-
Progress in the chemotherapeutic treatment of osteosarcoma.Oncol Lett. 2018 Nov;16(5):6228-6237. doi: 10.3892/ol.2018.9434. Epub 2018 Sep 12. Oncol Lett. 2018. PMID: 30405759 Free PMC article. Review.
-
Local dissemination of osteosarcoma observed after massage therapy: a case report.BMC Cancer. 2019 Oct 23;19(1):993. doi: 10.1186/s12885-019-6246-4. BMC Cancer. 2019. PMID: 31646993 Free PMC article.
-
Natural compounds as regulators of the cancer cell metabolism.Int J Cell Biol. 2013;2013:639401. doi: 10.1155/2013/639401. Epub 2013 May 16. Int J Cell Biol. 2013. PMID: 23762063 Free PMC article.
-
SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.J Transl Med. 2025 Feb 21;23(1):220. doi: 10.1186/s12967-025-06248-1. J Transl Med. 2025. PMID: 39985078 Free PMC article.
-
In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma.Pathol Oncol Res. 2022 Mar 22;28:1610231. doi: 10.3389/pore.2022.1610231. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35392503 Free PMC article.
References
-
- Longhi A, Errani C, De Paolis M, et al. Primary bone OS in the pediatric age: State of the art. Cancer Treatment Reviews. 2006;32:423–436. - PubMed
-
- Mckenna R, Schwinn CP, Soong KY, et al. Sarcomata of the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal osteogenic sarcoma, and sarcomata arising in abnormal bone) an analysis of 552 cases. J Bone Joint Surg. 1966;48:1–26.
-
- Iwamoto Y, Tanaka K, Isu K, et al. Multiinstitutional phase II study of neoadjuvant chemotherapy for OS (NECO study) in Japan: NECO-93J and NECO-95J. J Orthop Sci. 2009;14:397–404. - PubMed
-
- Meyers PA, Schwartz CL, Krailo M, et al. OS: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005;23:2004–2011. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous